RB
CELG

Rodgers Brothers’s Celgene Corp CELG Stock Holding History

Rodgers Brothers’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,893
Closed -$250K – 198
2018
Q4 		$250K Buy
3,893
+650
+20% +$48K 0.08% 166
2018
Q3 		$290K Hold
3,243
– – 0.08% 166
2018
Q2 		$258K Buy
+3,243
New +$269K 0.08% 172

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rodgers Brothers's CELG Position: Q1 2019 in Review

Rodgers Brothers sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3,893 shares — an estimated $250K sold.

Rodgers Brothers first reported a position in CELG in Q2 2018 and held it in 3 quarters. The position peaked at $290K in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Rodgers Brothers reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Rodgers Brothers sold 3,893 Celgene Corp shares in Q1 2019, an estimated $250K.
  • Rodgers Brothers first reported a position in Celgene Corp in Q2 2018 and held it in 3 quarters.
  • Rodgers Brothers's Celgene Corp position peaked at $290K in Q3 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Rodgers Brothers's 13F filing for Q1 2019, filed 15 May 2019.